Author

Maricarmen Vallejos

Université Paris-Sud

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aurélie TeissandieriD· 1 shared Caroline RobertiD· 1 shared Céline M. Labbé· 1 shared Delphine AllardiD· 1 shared Didier AuboeufiD· 1 shared Fabrice AndréiD· 1 shared Galina BoldinaiD· 1 shared Ivan BiècheiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Aurélie TeissandierORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MET functions in tumour progression and therapy resistance are repressed by intronic polyadenylation

Galina Boldina, Maricarmen Vallejos, Delphine Allard, Mandy Cadix, Céline M. Labbé, Sophie Vacher, Oskar Hemmingsson, Pierre Gestraud, Aurélie Teissandier, Sylvain Martineau, Didier Auboeuf, Fabrice André, Maud T Kamal, Nicolas Servant, Ivan Bièche, , Stéphan Vagner

The paper shows that intronic polyadenylation (IPA) of MET affects tumour progression and therapy resistance by producing a short MET isoform that reduces invasiveness and enhances response to MAPK-targeted therapy.

bioRxiv · Aug 9, 2023 · PreprintMolecular Biology